Ion beam diagnostic for the assessment of miniaturized electric propulsion systems.

Rev Sci Instrum

ThrustMe, Verrières-le-Buisson 91370, France.

Published: September 2020

An automated plume diagnostic system is presented for two-dimensional mapping of the ion beam produced by using miniaturized electric propulsion devices. The instrument is designed to operate with noble and reactive gases and consists of a semi-circular probe array with a unique angular distribution following a Gaussian shape for improved beam profile resolution. To demonstrate the operation of the diagnostic system, a series of experiments are conducted with a low-power gridded ion thruster using xenon and iodine propellants. The two-dimensional current density maps generated are used to calculate important beam properties for performance estimates, including the total ion current and the effective divergence angle, and we show how the measurements can be used to assess and optimize the design of ion optics for gridded ion thrusters. All current density measurements with the new instrument are corrected for secondary electron emission (SEE) due to ion bombardment, and using a separate, specially designed, electrostatic probe, we present the first measurements of the SEE yield for iodine ions impacting molybdenum and SAE 304 stainless steel surfaces.

Download full-text PDF

Source
http://dx.doi.org/10.1063/5.0010589DOI Listing

Publication Analysis

Top Keywords

ion beam
8
miniaturized electric
8
electric propulsion
8
diagnostic system
8
gridded ion
8
current density
8
ion
7
beam diagnostic
4
diagnostic assessment
4
assessment miniaturized
4

Similar Publications

Accurate dose predictions are crucial to maximizing the benefits of carbon-ion therapy. Carbon beams incident on the human body cause nuclear interactions with tissues, resulting in changes in the constituent nuclides and leading to dose errors that are conventionally corrected using conventional single-energy computed tomography (SECT). Dual-energy computed tomography (DECT) has frequently been used for stopping power estimation in particle therapy and is well suited for correcting nuclear reactions because of its detailed body-tissue elemental information.

View Article and Find Full Text PDF

The increasing interest in hadron therapy has heightened the need for accurate and reliable methods to assess radiation quality and the biological effectiveness of particles used in treatment. Microdosimetry has emerged as a key tool for this, demonstrating its potential, reliability, and suitability. In this context, solid-state microdosimeters offer technological advantages over traditional Tissue-Equivalent Proportional Counters, and recent advancements have further improved their performance and reliability.

View Article and Find Full Text PDF

Ultrasmall micro-light-emitting diodes (μLEDs), sized below 10 μm, are indispensable to create the next-generation augmented and virtual reality (AR/VR) devices. Their high brightness and low power consumption could not only enhance the user experience by providing vivid and lifelike visuals but also extend device longevity. However, a notable challenge emerges: a decrease in efficiency with a reduced size.

View Article and Find Full Text PDF

Purpose: The spot size of scanned particle beams is of crucial importance for the correct dose delivery and, therefore, plays a significant role in the quality assurance (QA) of pencil beam scanning ion beam therapy.

Materials And Methods: This study compares 5 detector types-radiochromic film, ionization chamber (IC) array, flat panel detector, multiwire chamber, and IC-for measuring the spot size of proton and carbon ion beams.

Results: Variations of up to 30% were found between detectors, underscoring the impact of detector choice on QA outcomes.

View Article and Find Full Text PDF

Spatial profiling of tissues promises to elucidate tumor-microenvironment interactions and generate prognostic and predictive biomarkers. We analyzed single-cell, spatial data from three multiplex imaging technologies: cyclic immunofluorescence (CycIF) data we generated from 102 breast cancer patients with clinical follow-up, and publicly available imaging mass cytometry and multiplex ion-beam imaging datasets. Similar single-cell phenotyping results across imaging platforms enabled combined analysis of epithelial phenotypes to delineate prognostic subtypes among estrogen-receptor positive (ER+) patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!